Central Lab Market - Top Companies and Manufacturers

In the year 2024, the industry size of central lab is assessed at USD 2.47 Billion.

The central lab market size was valued at USD 2.34 Billion in 2023 and is projected to reach USD 5.24 Billion by the end of 2036, registering around 6.4% CAGR during the forecast period i.e., between 2024-2036. Growing prevalence of genetic disorders, rise in genetic testing, increasing prevalence of cancer, and growing investment in R & D are some major factors driving the growth of the market.

North America is anticipated to account for largest industry share by 2036, led by high prevalence of infectious and chronic diseases, an increase in patient awareness about the significance of laboratory tests, increasing adoption of technological developments with proper quality, efficient and effective serve, and a significantly growing proportion of research and development in the region.

Laboratory Corporation of America Holdings (Labcorp), ICON Plc, Medpace, Inc., Eurofins Scientific (Ireland) Limited, LabConnect, Cerba Research NV, Frontage Laboratories, Inc., Lambda Therapeutic Research Limited, InVitro International (IVRO), Clinical Reference Laboratory, Inc